Novartis Investigative Site

Summary

Novartis Investigative Site is a medical facility located in San Antonio, Texas. This center is recognized for care of Postoperative Pain, Multiple Sclerosis, Type 2 Diabetes, Obesity, Nonalcoholic Steatohepatitis and other specialties. Novartis Investigative Site is involved with conducting 174 clinical trials across 166 conditions. There are 8 research doctors associated with this hospital, such as Nitendra Agarwal, Grant Garbo, MD, Hernan Alfonso Salazar, and EMANUEL PHILIP DE NOIA.

Top PIs

Clinical Trials running at Novartis Investigative Site

Obesity

Type 2 Diabetes

Cardiovascular Disease

Fatty Liver Disease

Atherosclerosis

Hepatitis

Liver Fibrosis

Fatty Liver

Postoperative Pain

Hypertriglyceridemia

LY4086940

for Obesity

The main purpose of this study is to evaluate the safety, tolerability of LY4086940 and how it is processed in the body. Participation in Part A of the study will last about 10 weeks and may include up to 6 visits. Participation in Parts B, C, D will last approximately 15 weeks and may include up to 9 visits. Participation in Part E will last approximately 7 weeks and may include up to 12 visits.

Recruiting

0 awards

Phase 1

1 criteria

LY3305677

for Obesity

The purpose of this Phase-2 chronic weight management master protocol (CWMM) is to create a framework to evaluate the safety and efficacy of various investigational interventions for chronic weight management with intervention-specific appendices (ISAs). The CWMM establishes entry criteria for newly enrolled participants across the master and the ISAs. The ISAs may start independently of other ISAs as interventions become available for clinical testing. The results for the CWMM screening record will be reported when all the ISA's complete.

Recruiting

0 awards

Phase 2

3 criteria